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Abstract
Depression among persons with HIV is associated with antiretroviral therapy (ART) interruption and discontinuation, 
virological failure, and poor clinical and survival outcomes. Case management services can address needs for emotional 
counseling and other supportive services to facilitate HIV care engagement. Using 2009–2013 North Carolina Medical 
Monitoring Project data from 910 persons engaged in HIV care, we estimated associations of case management utiliza-
tion with “probable current depression” and with 100% ART dose adherence. After weighting, 53.2% of patients reported 
receiving case management, 21.7% reported depression, and 87.0% reported ART adherence. Depression prevalence was 
higher among those reporting case management (24.9%) than among other patients (17.6%) (p < 0.01). Case management 
was associated with depression among patients living above the poverty level [adjusted prevalence ratio (aPR), 2.05; 95% 
confidence interval (CI) 1.25–3.36], and not among other patients (aPR, 1.01; 95% CI 0.72–1.43). Receipt of case man-
agement was not associated with ART adherence (aPR, 1.00; 95% CI 0.95–1.05). Our analysis indicates a need for more 
effective depression treatment, even among persons receiving case management services. Self-reported ART adherence was 
high overall, though lower among persons experiencing depression (unadjusted prevalence ratio, 0.92; 95% CI 0.86–0.99). 
Optimal HIV clinical and prevention outcomes require addressing psychological wellbeing, monitoring of ART adherence, 
and effective case management services.
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Resumen
La depresión en personas con VIH está asociada con la interrupción y descontinuación de terapia antirretroviral (TAR), fallo 
virológico, y resultados clínicos y de sobrevivencia deficientes. Los servicios de atención individualizada pueden abordar 
las necesidades de consejería emocional y otros servicios de apoyo para facilitar el enlace y cuidado del VIH. Con el uso 
datos del North Carolina Medical Monitoring Project (Proyecto del Monitoreo Médico de Carolina del Norte, MMP – por 
sus siglas en inglés) de 2009-2013, de 910 personas recibiendo cuidado para el VIH, estimamos asociaciones entre el uso de 
atención individualizada y “depresión actual probable” con 100% de cumplimiento de TAR. Después de ponderación, 53.2% 
de pacientes reportaron recibir atención individualizada, 21.7% reportaron depresión, y 87.0% reportaron cumplimiento con 
TAR. La prevalencia de depresión resultó ser más alta en aquellos reportando atención individualizada (24.9%) que en otros 
pacientes (17.6%) (p < 0.01). Hubo una asociación entre la atención individualizada y depresión en pacientes viviendo arriba 
del nivel de pobreza [tasa de prevalencia ajustada (aPR, 1.01; 95% intervalo de confianza (IC), 1.25-3.36], y no en otros 
pacientes (aPR, 1.01; 95% IC 0.72-1.43). No hubo asociación entre la recepción de atención individualizada y cumplim-
iento con TAR (aPR, 1.00; 95% IC 0.95-1.05). Nuestro análisis indica una necesidad para el tratamiento de depresión más 
efectivo, aún en personas recibiendo atención individualizada. Cumplimiento con TAR auto reportado resultó ser elevado 
generalmente, aunque bajo en personas enfrentando depresión (tasa de prevalencia no corregida, 0.92; 95% IC, 0.86-0.99). 
Extended author information available on the last page of the article
Resultados clínicos y de prevención de VIH óptimos requieren abordar el bienestar psicológico, monitoreo de cumplimiento 
con TAR, y servicios de atención individualizada efectivos.
Introduction
As recently emphasized in the U.S. National HIV/AIDS 
Strategy (NHAS): Updated to 2020, prompt diagnosis of HIV 
infection, timely linkage to and retention in care, antiretrovi-
ral therapy (ART) adherence, and resources for unmet needs 
are important for effective HIV treatment and prevention. 
Primary NHAS goals include increasing the percentage of 
persons with HIV who are retained in HIV medical care to 
at least 90%, and increasing the percentage who are virally 
suppressed to at least 80% [1].
Depression, the most prevalent psychiatric disorder 
among persons with HIV other than substance use disor-
ders, has important implications for patient retention, quality 
of life, and HIV transmission [2]. Depression prevalence 
among persons with HIV engaged in HIV care is 20%–30% 
[3], at least twice the depression prevalence in the general 
United States (US) population [4, 5]. Depression and depres-
sive symptoms are associated with poorer ART adherence 
[6, 7], which is associated in turn with virological failure [8, 
9] and poorer immunological outcomes [8], increasing the
likelihood of poor health and HIV transmission [10].
One approach both to facilitating treatment of depres-
sion and to improving ART adherence is the provision of 
case management services [11], which have been used to 
decrease unmet need for supportive services and to improve 
HIV medical care among persons with HIV [12, 13]. Most 
studies assessing the effectiveness of case management for 
persons with HIV have described the ability of these ser-
vices to increase linkage to care [14–17], ART uptake [18], 
and virologic suppression [19], and to decrease unmet need 
for emotional counseling [18]. Few studies have examined 
the relationship between case management services and cur-
rent depression or depressive symptoms among persons with 
HIV [20]. In addition, the role of case management services 
in facilitating ART adherence has not been well established 
[21, 22].
In North Carolina (NC), case management services are 
offered to clients based on apparent need and availability of 
services. The services may be provided through the Ryan 
White HIV/AIDS Program, which provides funding for state 
and local programs to assist low-income persons with HIV 
through medical case management, oral health management, 
home health care, transportation assistance, hospice care, 
and the AIDS Drug Assistance Program (ADAP) [23]. Pub-
lic health officials continue to see increases in the HIV bur-
den among low-income residents in southern states, where 
financial strain, psychosocial trauma, substance use, and 
long travel distance to providers are correlated with a high 
prevalence of mental health illnesses [24]. In addition, pov-
erty, poor healthcare infrastructures, legislative policies, and 
stigma contribute to the HIV burden in southern states [25]. 
In 2015, the HIV prevalence rate among persons living with 
diagnosed or undiagnosed HIV in NC was 414.1 per 100,000 
person-years [26]. The rate of new HIV diagnoses in 2016 
was 16.8 per 100,000 person-years in the South, compared 
to 11.2, 10.2, and 7.5 in the Northeast, West, and Midwest, 
respectively [27]. In the same year, NC ranked 6th among 
US states in the number of new diagnoses (n = 1414), with 
16.5 per 100,000 person-years [27, 28]. Improved under-
standing of the relationships between case management 
service provision and both depression and ART adherence 
is needed, particularly among persons residing in NC with 
barriers to medical care access.
We used 2009–2013 data from the Medical Monitor-
ing Project (MMP), a national survey of persons with HIV 
receiving medical care, to assess the prevalence and corre-
lates of case management services, probable current depres-
sion, and 100% ART dose adherence in NC [29]. We also 
examined the associations between case management utiliza-
tion and both depression and ART adherence in this setting.
Methods
Medical Monitoring Project (MMP)
MMP is a supplemental HIV surveillance system that uses a 
three-stage probability proportional to size sampling design 
to obtain nationally representative, annual cross-sectional 
samples of adults receiving outpatient HIV medical care in 
the US. The multi-stage sampling scheme and weighting 
procedures have been described in detail [30–32]. NC was 
randomly selected as one of the primary sampling units in 
the first sampling stage. For each of the five cycles of data we 
analyzed (annual cross-sections in 2009–2013), MMP first 
sampled outpatient facilities in NC with probability propor-
tional to estimated patient load, and then used comprehen-
sive lists obtained from the facilities to sample adults living 
with HIV aged 18 years or older who had at least one HIV 
medical care visit in a participating facility between January 
and April of the cycle year. Data were collected via face-
to-face interviews between June of the cycle year and May 
of the subsequent year (e.g., 2009 cycle collection = June 
2009–May 2010). The overall response rates for 2009–2013, 
combining facilities and patients and adjusting for unknown 
eligibility, were 39.4, 30.4, 26.3, 30.9, and 48.5%, respec-
tively. The resulting interview data included a total of 910 
respondents with HIV: 602 males (67.2%), 297 females 
(31.3%), 10 transgender persons (1.3%), and 1 intersex per-
son (0.1%). Among self-identified transgender persons, data 
on transmen and transwomen were not available for analysis.
The first half of the twelve-section MMP question-
naire asked participants about demographic characteristics 
(including age, education status, and sexual orientation), 
personal experiences regarding access to HIV care, and 
related barriers (e.g., HIV testing and care experiences, met 
and unmet needs, stigma and discrimination, etc.). The sec-
ond half of the questionnaire included questions on sexual 
behaviors, substance abuse, transmission risk factors, part-
ners’ behaviors, gynecological and reproductive history, 
health conditions and preventive therapy, HIV prevention 
activities, and depression.
Case Management Utilization, Depression, and ART 
Adherence
Our exposure of interest, case management utilization, was 
assessed based on responses to the MMP question, “During 
the past 12 months, did you get case management services?” 
There were no other survey items on case management, nor 
did the questionnaire provide a specific definition for case 
management services.
Depression, our first outcome of interest, was identified 
from responses on the 8-item Patient Health Questionnaire 
(PHQ-8) [33]. For the analysis, we coded probable current 
depression (major or other) based on Kroenke and Spitzer’s 
2002 algorithm of experiencing at least two depressive 
symptoms for ‘‘more than half the days’’ in the preceding 
2 weeks, with at least one symptom being depressed mood 
or anhedonia. We defined the depression outcome as “prob-
able current depression” (though for succinctness our results 
refer simply to “depression”) due to the lack of diagnosis by 
a licensed clinician.
Kroenke and Spitzer’s algorithm yields similar classifica-
tions as a total PHQ-8 score ≥ 10, which we also examined 
in sensitivity analyses as a second operational definition of 
probable current depression [33, 34]. The PHQ-8 assigns a 
score for the number of days in the previous 2 weeks that the 
respondent experienced each of the eight criteria for depres-
sion from the Diagnostic and Statistical Manual of Mental 
Disorders, fourth edition (DSM-IV) [35]. Each PHQ item is 
scored as 0 (“not at all” in the previous 2 weeks), 1, 2, or 3 
(“nearly every day”), yielding total PHQ-8 scores between 
0 and 24. Although suicide is an important problem, espe-
cially among persons living with HIV, with approximately 
1 in 5 reporting suicidal ideation in the previous week [36], 
MMP did not use the PHQ item for suicidal or self-injurious 
ideation because interviewers were not trained mental health 
providers. Studies have shown that exclusion of the 9th item 
does not have considerable effects on scoring because self-
injurious ideation is uncommon in the general population 
and in primary care settings [34, 37–41]. Original valida-
tion studies have shown that the PHQ-8 is comparable to 
the PHQ-9, and identical scoring thresholds for measuring 
current depression can be used for both questionnaires [34].
ART adherence, our second outcome of interest, was 
defined as 100% ART dose adherence in the past 3 days, an 
AIDS Clinical Trials Group measure [42]. At the time of 
interview, participants were asked, “In the past 3 days, were 
you 100% dose adherent to your ART medicine?” ART dose 
was defined as either a single tablet or multiple tablets taken 
concurrently. If the respondent missed part of a dose, he or 
she was instructed to report this as a missed dose. Partici-
pants living with HIV were recorded as either 100% ART 
dose adherent or not 100% ART dose adherent in the past 
72 hrs. on the basis of this question. In sensitivity analyses, 
we also analyzed ART schedule adherence, which was based 
on the MMP question, “In the past 3 days, were you 100% 
schedule adherent to your ART medicine?”
Additional Measures
Various characteristics were considered as potential cor-
relates and/or effect measure modifiers of the associa-
tions between utilization of case management services in 
the previous 12 months and our two outcomes (probable 
current depression and 100% ART dose adherence in the 
past 3  days). Sociodemographic factors included age 
(18–29, 30–39, 40–49, ≥ 50 years), gender (men, women, 
transgender/intersex), race/ethnicity (non-Hispanic White, 
non-Hispanic Black, Hispanic/Latino, other), sexual orien-
tation (heterosexual, homosexual, bisexual, other/unclas-
sified), education (< high school, high school or equiva-
lent, > high school), annual household income ($0–$19,999, 
$20,000–$39,999, $40,000–$74,999, ≥ $75,000), federal 
poverty level (living at or below, versus above, the poverty 
level, defined per 2012 standards using household income 
and size) [43], and health insurance (public or private, Ryan 
White/ADAP only, uninsured). Because NC has many rural 
areas requiring long travel distances to visit medical pro-
viders, we examined the need for transportation assistance 
services in the previous 12 months (yes/no). Behavioral fac-
tors of interest included alcohol consumption in the previous 
12 months (yes/no) and current smoking status (yes/no).
Analytical Methods
MMP respondents with missing or incomplete data on case 
management utilization, depression, or ART adherence were 
excluded from analyses using those variables. Patients not 
taking ART were excluded from the denominator for adher-
ence percentages. The distributions of sociodemographic 
and behavioral variables, utilization of case management 
services in the previous 12 months, probable current depres-
sion, and 100% ART dose adherence in the past 3 days were 
summarized with unweighted counts and weighted percent-
ages. All variables were coded as dichotomous, nominal, or 
ordinal categorical. Bivariable associations of sociodemo-
graphic and behavioral characteristics with (1) case man-
agement utilization in the previous 12 months, (2) probable 
current depression, and (3) 100% ART dose adherence in 
the past  3 days were examined with Rao–Scott Chi square 
statistics that accounted for the survey design, and preva-
lence ratios (PRs) with 95% confidence intervals (CIs) 
obtained from weighted Poisson models with robust vari-
ance estimation.
We estimated the association between case management 
utilization in the past 12 months and each of our two out-
come variables (probable current depression and 100% ART 
dose adherence) using weighted multivariable Poisson mod-
els with robust variance to account for any violations of the 
distribution assumptions. Since associations in our cross-
sectional data could reflect (1) targeting of case management 
services with respect to prior (unmeasured) depression and 
ART adherence status, as well as (2) any effects of past-year 
case management services on current depression and ART 
adherence status, our interest in estimating these associa-
tions was not to infer causality between case management 
and our outcomes. Rather, our intent was to assess current 
unmet need for depression treatment and ART adherence 
support according to prior case management utilization, such 
that targets for future investigation and intervention could 
be identified.
In model development, all other variables (i.e., sociode-
mographic variables) were assessed as potential confounders 
or effect measure modifiers of the associations between the 
exposure (i.e., case management utilization) and each of the 
two outcomes (i.e., probable current depression, 100% ART 
dose adherence). We identified potential confounders of the 
associations between case management and both depression 
and ART dose adherence (separately) based on a literature 
review and directed acyclic graphs [44]. We assessed effect 
measure modification for each predictor variable in the 
models using a product interaction term and an adjusted 
Wald test with alpha = 0.15 to increase power to detect true 
interactions [45]. We assessed collinearity among variables 
using variance inflation factors; none was detected. Analyses 
were performed using Stata version 14 (StataCorp, College 
Station, TX) and SAS 9.4 (SAS Institute Inc., Cary, NC). 
Except where noted, all analyses incorporated the MMP-
provided sample design and weights, to account for cluster-
ing, unequal selection, and nonresponse.
Results
Patient Characteristics
Adults with HIV receiving care in NC during 2009–2013 
were predominantly age 40 years and older (74.8%), men 
(67.2%), non-Hispanic Black (61.6%), and heterosexual 
(59.3%) (see Table 1). Slightly more than half (54.6%) had 
more than a high school education. A majority (62.6%) 
reported a yearly household income less than $20,000; 
45.5% were living at or below the poverty level [43]. Most 
(75.0%) reported having public or private health insurance 
coverage in the previous 12 months; 22.3% reported hav-
ing only Ryan White/ADAP coverage, and 2.7% (n = 25) 
reported having no coverage. About one-fourth needed trans-
portation assistance. A majority of patients used alcohol in 
the previous 12 months (64.0%) and a large minority were 
current smokers (43.7%). Just over half of patients (53.2%) 
reported using case management services in the previous 
12 months. Approximately one in five patients (21.7%) expe-
rienced probable current depression, and 87.0% of patients 
receiving ART reported being 100% ART dose adherent in 
the past 3 days. A total of 8.6% of participants were not 
receiving ART.
Factors Associated with Case Management 
Utilization in Bivariable Analyses
Women were more likely to utilize case management ser-
vices in the previous 12 months than were men (PR, 1.15; 
95% CI 1.01–1.31), as were patients with less than a high 
school education (PR, 1.43; 95% CI 1.21–1.69, versus those 
with more education) (results not shown). Respondents liv-
ing at or below the poverty level were more likely to receive 
case management services than those living above the 
poverty line (PR, 1.42; 95% CI 1.22–1.66). Patients who 
received assistance from Ryan White/ADAP (versus private 
or public insurance), needed transportation assistance in the 
previous 12 months, or reported current smoking were all 
more likely to have received case management services in 
the previous 12 months.
Factors Associated with Probable Current 
Depression in Bivariable Analyses
Women were more likely than men to be currently depressed 
(PR, 1.44; 95% CI 1.17–1.77), as were those living at or 
below the poverty level (PR, 1.59; 95% CI 1.15–2.19, versus 
those living above the poverty level) (see Table 2). The prev-
alence of depression was also greater for those who needed 
transportation assistance (PR, 1.66; 95% CI 1.25–2.19), as 
Table 1  Sociodemographic 
and behavioral characteristics 
of participants in the North 
Carolina Medical Monitoring 
Project, 2009–2013
Unweighted N Weighted %a 95%  CIb
Total N 910
Age
 18–29 52 6.1 (4.1–8.1)
 30–39 164 19.1 (15.4–22.7)
 40–49 307 34.1 (31.0–37.2)
  ≥ 50 387 40.7 (36.1–45.2)
Gender
 Men 602 67.2 (63.8–70.7)
 Women 297 31.3 (28.0–34.6)
 Transgender 10 1.3 (0.48–2.29)
 Intersex 1 0.1 (0.00–0.38)
Race/ethnicity
 Non–Hispanic White 267 29.4 (23.4–35.5)
 Non-Hispanic Black 561 61.6 (54.5–68.7)
 Hispanic or Latino 25 2.9 (1.7–4.1)
 Other 57 6.1 (4.2–8.1)
Sexual orientation
 Heterosexual 548 59.3 (54.0–64.7)
 Homosexual 283 31.6 (26.4–36.8)
 Bisexual 71 8.0 (6.1–9.7)
 Other/unclassified 8 1.1 (0.3–1.9)
Education
> High school 501 54.6 (48.6–60.6)
High school or equivalent 237 26.7 (21.5–31.9)
 < High school 172 18.7 (15.4–22.0)
Income (annual household)c
 $0–$19,999 538 62.6 (57.7–67.4)
 $20,000–$39,999 174 21.3 (18.6–24.1)
 $40,000–$74,999 94 11.1 (8.3–14.0)
  ≥ $75,000 44 5.0 (3.2–6.8)
Poverty  levelc
 Above poverty level 457 54.5 (50.2–58.9)
 At or below poverty level 393 45.5 (41.1–49.8)
Health insurance (past 12 months)c
 Yes (Public or Private) 691 75.0 (70.9–79.0)
 Uninsured (Ryan White/ADAP only) 192 22.3 (18.7–25.9)
 Uninsured 25 2.7 (1.5–3.9)
Needed transportation (past 12 months)
 No 671 74.3 (71.0–77.6)
 Yes 239 25.7 (22.4–29.0)
Alcohol use (past 12 months)c
 No 334 36.0 (31.9–40.1)
 Yes 572 64.0 (60.0–68.1)
Current  smokerc
 No 507 56.3 (51.8–60.8)
 Yes 399 43.7 (39.2–48.2)
Case management services (past 12 months)c
 No 433 46.8 (41.4–52.2)
 Yes 474 53.2 (47.8–58.6)
100% ART dose adherence (past 3 days)c,d
 Yes, 100% ART dose adherent 709 79.6 (77.0–82.2)
well as for current smokers (PR, 1.40; 95% CI 1.07–1.85, 
versus non-smokers). Persons who received case manage-
ment services in the previous 12 months were 41% more 
likely to be depressed (PR, 1.41; 95% CI 1.09–1.83, versus 
persons who did not). We found no statistically significant 
associations between probable current depression and age, 
race/ethnicity, sexual orientation, education, income, health 
insurance status, or alcohol use (past 12 months).
Factors Associated with 100% ART Dose Adherence 
in Bivariable Analyses
Women were less likely than men to report 100% ART dose 
adherence in the past 3 days (PR, 0.92; 95% CI 0.86–0.98), 
as were non-Hispanic Blacks (PR, 0.92; 95% CI 0.88–0.96, 
versus non-Hispanic Whites) (see Table 3). Respondents 
with less than a high school education were 10% less likely 
(PR, 0.90; 95% CI 0.83–0.98) to be adherent compared to 
individuals with more than a high school education. Persons 
living at or below the poverty level were 7% less likely (PR, 
0.93; 95% CI 0.87–0.99) to be adherent compared to per-
sons living above the poverty level. Current smokers were 
less likely to be adherent compared to non-smokers (PR, 
0.91; 95% CI 0.85–0.98). Patients reporting probable cur-
rent depression were less likely to be adherent than those not 
experiencing probable current depression (PR, 0.92; 95% CI 
0.86–0.99). We found no associations between 100% ART 
dose adherence in the past 3 days and age, sexual orienta-
tion, income, health insurance status, need for transportation 
assistance (past 12 months), or alcohol use (past 12 months).
Multivariable Associations Between the Exposure 
and Outcomes of Interest
We found poverty level to be a significant effect measure 
modifier of the association between case management uti-
lization in the previous 12 months and probable current 
depression (Wald p-value = 0.02; N = 58 respondents were 
missing data on poverty). After adjustment for gender, 
sexual orientation, education, annual household income, 
health insurance status, and need for transportation assis-
tance, utilization of case management services in the previ-
ous 12 months was associated with probable current depres-
sion among persons living above the poverty level (adjusted 
prevalence ratio [aPR], 2.05; 95% CI 1.25–3.36), but not 
among those living at or below the poverty level (aPR, 
1.01; 95% CI 0.72–1.43) (N = 842; 10 participants were 
missing data on case management utilization and/or prob-
able current depression) (see Table 4). Similar associations 
were obtained in sensitivity analyses where depression was 
defined as a PHQ-8 score ≥ 10 (aPR, 2.05; 95% CI 1.31–3.20 
for above poverty level; aPR, 0.91; 95% CI 0.64–1.30 for at 
or below poverty level).
Adjusted for gender, race/ethnicity, education, annual 
household income, poverty level, health insurance status, 
need for transportation assistance (past 12 months), and 
probable current depression, 100% ART dose adherence 
did not differ between those who did or did not receive case 
management services in the past 12 months (aPR, 1.00; 
95% CI 0.95–1.05), nor did 100% ART schedule adherence 
(aPR, 1.01; 95% CI 0.95–1.08) (N = 812; 21 participants 
were missing data on case management utilization and/or 
ART adherence, and 77 were not taking ART).
Discussion
The Southern region of the US has disproportionately high 
HIV infection rates [46] and greater political, societal, and 
structural barriers to optimal clinical outcomes and preven-
tion of HIV transmission [25]. This study is one of the first 
to report prevalence estimates of case management utiliza-
tion, current depression, and ART adherence using repre-
sentative data on persons with HIV receiving HIV medical 
care in a southern state.
Among persons receiving HIV medical care in our set-
ting, 53.2% reported receiving case management services 
in the past 12 months. It is difficult to place this estimate in 
context, since the only available national estimate—56.5%—
was reported from the 1996–1997 HIV Cost and Services 
Table 1  (continued) Unweighted N Weighted %a 95%  CIb
 No, not 100% ART dose adherent 106 11.9 (9.2–14.5)
 Not taking ART 77 8.6 (6.1–11.0)
Probable current  depressionc
 No 706 78.3 (75.2–81.4)
 Yes 197 21.7 (18.6–24.8)
a Percentages are weighted to account for probability of selection and nonresponse
b 95% confidence interval
c Frequencies do not add up to total sample size (n = 910) due to missing data
d ART = antiretroviral therapy
Table 2  Probable 
current depression by 
sociodemographic and 
behavioral characteristics, North 
Carolina Medical Monitoring 
Project, 2009–2013
a Percentages are weighted to account for probability of selection and nonresponse
b PR (95% CI) = crude estimate of prevalence ratio and 95% confidence interval from Poisson regression
cp -value from Rao–Scott Chi square statistic
d Frequencies do not add up to total depression sample size (N = 195) due to missing data
Probable current depres-
sion
PR (95% CI)b Χ2 p-valuec
N %a
Total (N = 900) 195 21.5
Age
 18–29 8 13.3 1.0 0.27
 30–39 39 23.0 1.72 (0.70–4.26)
 40–49 73 24.4 1.83 (0.86–3.91)
  ≥ 50 75 19.7 1.48 (0.69–3.17)
Gender
 Men 115 19.1 1.0 < 0.01
 Women 80 27.6 1.44 (1.17–1.77)
 Transgender/intersex 0 – –
Race/ethnicity
 Non-Hispanic White 63 23.2 1.0 0.76
 Non-Hispanic Black 113 20.3 0.87 (0.65–1.18)
 Hispanic or Latino 6 24.7 1.07 (0.52–2.18)
 Other 13 23.9 1.03 (0.58–1.82)
Sexual orientation
 Heterosexual 124 22.8 1.0 0.08
 Homosexual 51 17.8 0.78 (0.62–0.98)
 Bisexual/other/unclassified 20 26.2 1.15 (0.79–1.68)
Education
> High school 98 19.8 1.0 0.39
 High school or equivalent 57 23.9 1.21 (0.95–1.54)
  < High school 40 23.1 1.17 (0.78–1.74)
Income (annual household)d
 $0–$19,999 131 24.6 1.0 0.07
 $20,000–$39,999 31 16.7 0.68 (0.42–1.08)
 $40,000–$74,999 11 14.1 0.57 (0.31–1.03)
  ≥ $75,000 7 16.5 0.67 (0.34–1.34)
Poverty  leveld
 Above poverty level 76 16.8 1.0 < 0.01
 At or below poverty level 104 26.7 1.59 (1.15–2.19)
Health insurance (past 12 months)d
 Yes (public or private) 151 21.8 1.0 0.90
 Uninsured (Ryan White/ADAP only) 37 20.3 0.93 (0.66–1.31)
 Uninsured 6 20.0 0.92 (0.42–2.00)
Needed transportation assistance (past 12 months)
 No 124 18.4 1.0 < 0.01
 Yes 71 30.5 1.66 (1.25–2.19)
Alcohol use (past 12 months)d
 No 78 23.2 1.0 0.30
 Yes 117 20.6 0.89 (0.71–1.11)
Current  smokerd
 No 92 18.2 1.0 0.01
 Yes 102 25.6 1.40 (1.07–1.85)
Case management services (past 12 months)
 No 77 17.6 1.0 < 0.01
 Yes 118 24.9 1.41 (1.09–1.83)
Utilization Survey (HCSUS) and pertained to a shorter 
6-month period prior to interview [18]. The probable cur-
rent depression prevalence for persons with HIV in care in 
NC based on 2009–2013 MMP data was 21.7%, which is 
somewhat lower than the 25.6% reported from national 2009 
MMP data [5]. Both estimates are about twice their corre-
sponding estimates among the general US population [4].
As is regularly observed [5, 47–49], women were more 
likely than men to suffer from probable current depres-
sion. Persons with HIV in care with a need for transporta-
tion assistance were more likely to be depressed, consistent 
with prior studies of the relationship between mental illness 
and needs for supportive services [50, 51]. We found no 
differences in depression in relation to sexual orientation. 
One study reported that gay men with HIV living in non-
metropolitan areas were more likely to suffer from depres-
sion, which was largely driven by social constraints [52]. 
We likely underestimated the proportion of persons with 
HIV in medical care who are men who have sex with men 
due to low recruitment of respondents self-identifying as 
homosexual. As men who have sex with men often face dis-
crimination in health care settings, improved recruitment of 
these men in studies is important [53].
Among patients with incomes at or below the poverty 
level, both receipt of case management services and depres-
sion prevalence were higher than among patients above the 
poverty level, but there was no association between case 
management and depression. By contrast, among patients 
with household incomes above the poverty level, receipt of 
case management services and current depression were posi-
tively associated. We speculate that the association among 
patients above the poverty level reflects the targeting of case 
Table 3  100% ART dose adherence in the past 3 days by sociodemo-
graphic and behavioral characteristics, North Carolina Medical Moni-
toring Project, 2009–2013
100% 
ART dose 
adherence
PR (95% CI)b Χ2 p-valuec
N %a
Total (N = 812) 706 87.0
Age
 18–29 35 86.5 1.0 0.35
 30–39 124 87.1 1.01 (0.87–1.16)
 40–49 228 84.2 0.97 (0.85–1.12)
  ≥ 50 319 89.3 1.03 (0.90–1.18)
Gender
 Men 487 89.3 1.0 0.02
 Women 212 82.4 0.92 (0.86–0.98)
 Transgender/intersex 7 71.1 0.80 (0.49–1.29)
Race/ethnicity
 Non-Hispanic White 230 92.3 1.0 < 0.01
 Non-Hispanic Black 420 84.6 0.92 (0.88–0.96)
 Hispanic or Latino 20 94.7 1.03 (0.92–1.15)
 Other 36 79.6 0.86 (0.75–1.00)
Sexual orientation
 Heterosexual 415 85.5 1.0 0.25
 Homosexual 232 89.2 1.04 (0.99–1.10)
 Bisexual/other/unclas-
sified
59 88.6 1.04 (0.95–1.13)
Education
> High school 407 89.4 1.0 < 0.01
 High school or equiva-
lent
178 86.3 0.97 (0.91–1.02)
  < High school 121 80.5 0.90 (0.83–0.98)
Income (yearly household)d
 $0–$19,999 409 85.3 1.0 0.10
 $20,000–$39,999 134 85.6 1.00 (0.92–1.09)
 $40,000–$74,999 79 94.8 1.11 (1.03–1.19)
 ≥ $75,000 37 91.7 1.08 (0.97–1.19)
Poverty  leveld
 Above poverty level 375 89.6 1.0 0.02
 At or below poverty 
level
284 83.2 0.93 (0.87–0.99)
Health insurance (past 12 months)
 Yes (public or private) 536 87.0 1.0 0.99
 Ryan White/ADAP 
only
163 86.8 1.00 (0.94–1.06)
 Uninsured 7 86.1 0.99 (0.78–1.25)
Needed transportation assistance (past 12 months)
 No 531 88.0 1.0 0.25
 Yes 175 84.0 0.95 (0.88–1.04)
Alcohol use (past 12 months)d
 No 262 85.9 1.0 0.47
 Yes 442 87.6 1.02 (0.97–1.08)
a Percentages are weighted to account for probability of selection and 
nonresponse; ART = antiretroviral therapy
b PR (95% CI) = crude estimate of prevalence ratio and 95% confi-
dence interval from Poisson regression
c p-value from Rao–Scott Chi square statistic
d Frequencies do not add up to total 100% ART dose adherence sam-
ple size (N = 706) due to missing data
Table 3  (continued)
100% 
ART dose 
adherence
PR (95% CI)b Χ2 p-valuec
N %a
Current  smokerd
 No 413 90.4 1.0 0.01
 Yes 291 82.4 0.91 (0.85–0.98)
Probable current  depressiond
 No 563 88.6 1.0 0.01
 Yes 140 81.6 0.92 (0.86–0.99)
management services to persons suffering from depression, 
whereas among those at or below the poverty line, case 
management services would be indicated for many reasons 
besides depression. In NC, persons with HIV living in pov-
erty utilize case management services for access to medical 
care, food, job resources, shelter, and transportation. How-
ever, 32.3% of patients above the poverty level had yearly 
household incomes of $20,000 or less, so an array of unmet 
needs may be common for a sizeable minority of that group 
as well.
The prevalence of self-reported 100% ART dose adher-
ence in the past 3 days among persons receiving care and 
on ART in NC was high (87.0%), and similar to the 86.0% 
prevalence reported using national MMP data from the 
2009–2010 cycle [54]. Non-Hispanic Blacks, women, and 
persons living at or below the poverty level were less likely 
to be 100% ART dose adherent, as also seen in the national 
MMP data [54]. The 100% ART dose adherence prevalence 
estimates were similar for respondents who received case 
management and those who did not (aPR, 1.00; 95% CI 
0.95–1.05). It is possible that appropriately targeted case 
management services boosted adherence among persons 
who would otherwise have been non-adherent, but our cross-
sectional design precludes estimation of such an effect. An 
important qualifier is that 8.6% of patients were not taking 
ART, conceivably because they did not perceive a need to 
initiate ART, were judged likely to have poor adherence, or 
were not treatment-eligible on the basis of clinical guidelines 
at the time of interview.
The high prevalence of depression, even among those 
receiving case management services, warrants public health 
attention and suggests the need for additional resources for 
case managers, or more support from providers and mental 
health professionals. In a previous study, a sample of HIV/
AIDS case managers across NC participating in a three-
month intensive case management training and adherence 
program reported client-level challenges to adherence such 
as depression, which were often associated with geographic 
barriers (e.g., rural residents with transportation needs) and 
social isolation. Several case managers felt they were not 
knowledgeable about adherence coordination and coun-
seling or ART medication [55]. Meeting the mental health 
needs of persons with HIV requires accessible and effective 
mental health resources, working in coordination with case 
managers.
A limitation of our study is its cross-sectional design, 
in which history of case management utilization, prob-
able current depression status, and ART adherence were 
ascertained simultaneously. The case management survey 
item provided no information pertaining to frequency of 
services or the reason they were provided, preventing us 
from examining the relationships between those impor-
tant case management aspects and both ART adherence 
and depression. As noted above, if case management was 
Table 4  Associations between utilization of case management services and probable current depression, and 100% ART dose adherence, North 
Carolina Medical Monitoring Project, 2009–2013
a Percentages are weighted to account for probability of selection and nonresponse
b Adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) calculated using multivariable Poisson models adjusted for gender, sexual 
orientation, education, income, health insurance, need for transportation; analyses weighted to account for complex sample design
c 100% ART dose adherence (past 3 days); ART = antiretroviral therapy
d Adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) calculated using multivariable Poisson models adjusted for gender, race/
ethnicity, education, income, poverty, health insurance, need for transportation, probable current depression; analyses weighted to account for 
complex sample design
Total (N = 842) Probable current depression Prevalencea PR aPR
Yes (N) No (N) (%) (95% CI) (95% CI)b
Case management utilization (past 12 months)
At or below poverty level
 Utilized case management 63 173 27.0 1.02 (0.73–1.44) 1.01 (0.72–1.43)
 Did not utilize case management 41 112 26.4 1.0 1.0
Above poverty level
 Utilized case management 45 150 23.0 1.90 (1.26–2.87) 2.05 (1.25–3.36)
 Did not utilize case management 31 227 12.1 1.0 1.0
Total (N = 812) 100% ART dose  adherencec Prevalencea PR aPR
Yes (N) No (N) (%) (95% CI) (95% CI)d
Case management utilization (past 12 months)
 Utilized case management 374 64 85.6 0.97 (0.92–1.02) 1.00 (0.95–1.05)
 Did not utilize case management 332 42 88.7 1.0 1.0
targeted to the subset of persons above the poverty level 
who were depressed, their depression prevalence may have 
declined from even higher levels but still be higher than 
among patients to whom case management was not pro-
vided. Among persons living at or below the poverty level, 
an even higher percentage of patients receiving case man-
agement might have been depressed without it. However, 
the cross-sectional design does not allow us to disentangle 
the extent to which effect estimates reflect case manage-
ment targeting versus case management effects. Direct 
assessment of the effectiveness of case management to 
facilitate depression treatment and ART adherence will 
require prospective measurement of all three factors and 
appropriate analytical methods to account for time-varying 
relationships, repeated intra-individual measures, and bidi-
rectional causality.
Another limitation of our study is that information was 
self-reported and therefore subject to potential social desir-
ability and recall biases, particularly in the case of ART 
adherence reporting. Self-reported adherence is known to 
overestimate adherence and is the least accurate of all meas-
ures, however, it is commonly used in HIV clinical care for 
efficiency [56] and was used in a previous study assessing 
ART dose adherence using national MMP data [54]. In addi-
tion, we did not consider geographical data with respect to 
the participants’ residences. With inconsistent quality and 
accessibility of health care services in the South, location 
information may shed light on particular barriers faced by 
individuals in certain geographic regions within NC [57].
Optimal HIV clinical and prevention outcomes require 
identifying persons with HIV, linking them to and retain-
ing them in care, prescribing appropriate ART, maintaining 
adherence, and achieving and maintaining viral suppression. 
These processes, in turn, require addressing unmet needs and 
psychological wellbeing, monitoring their impacts on ART 
adherence, and ensuring the effectiveness of mental health 
and other medical services. Case management and mental 
health agencies must be adequately funded, monitored, and 
evaluated to ensure that persons in HIV care are receiving 
assistance to improve HIV-related health outcomes.
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